Point of Care Urine Testing Study
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Authenticity of Point-of-Care Urine Samples Using Oral Fluorescein Sodium in Adults Ages 18-65 with Substance Use Disorder. This study involves 2 visits to our clinic (Guelph, ON) and 1 phone call visit over a 1 month period. Involves multiple urine samples and 1 blood draw.
